Miniatura

Fitxers

journal.pntd.0007216.pdf (712.38 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2019-03-27

Llicència de publicació

cc0 (c) Chakravarty et al., 2019
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/134893

Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1371/journal.pntd.0007216

Resum

Background: Asymptomatic Leishmania donovani infections outnumber clinical presentations, however the predictors for development of active disease are not well known. We aimed to identify serological, immunological and genetic markers for progression from L. donovani infection to clinical Visceral Leishmaniasis (VL). Methods: We enrolled all residents >2 years of age in 27 VL endemic villages in Bihar (India). Blood samples collected on filter paper on two occasions 6–12 months apart, were tested for antibodies against L. donovani with rK39-ELISA and DAT. Sero converters, (negative for both tests in the first round but positive on either of the two during the second round) and controls (negative on both tests on both occasions) were followed for three years. At the start of follow-up venous blood was collected for the following tests: DAT, rK39- ELISA, Quantiferon assay, SNP/HLA genotyping and L.donovani specific quantitative PCR. Results: Among 1,606 subjects enrolled,17 (8/476 seroconverters and 9/1,130 controls) developed VL (OR 3.1; 95% CI 1.1–8.3). High DAT and rK39 ELISA antibody titers as well as positive qPCR were strongly and significantly associated with progression from seroconversion to VL with odds ratios of 19.1, 30.3 and 20.9 respectively. Most VL cases arose early (median 5 months) during follow-up. Conclusion: We confirmed the strong association between high DAT and/or rK39 titers and progression to disease among asymptomatic subjects and identified qPCR as an additional predictor. Low predictive values do not warrant prophylactic treatment but as most progressed to VL early during follow-up, careful oberservation of these subjects for at least 6 months is indicated.

Matèries

Leishmaniosi, Genètica molecular

Matèries (anglès)

Leishmaniasis, Molecular genetics

Citació

Col·leccions

Articles publicats en revistes (ISGlobal)

Citació

CHAKRAVARTY, Jaya, HASKER, Epco c., KANSAL, Sangeeta, SINGH, Om prakash, MALAVIYA, Paritosh, SINGH, Abhishek kumar, CHOURASIA, Ankita, SINGH, Toolika, SUDARSHAN, Medhavi, SINGH, Akhil pratap, SINGH, Bhawana, SINGH, Rudra pratap, OSTYN, Bart, FAKIOLA, Michaela, PICADO DE PUIG, Albert, MENTEN, Joris, BLACKWELL, Jenefer m., WILSON, Mary elisabeth, SACKS, David, BOELAERT, Marleen, SUNDAR, Shyam. Determinants for progression from asymptomatic infection to
                symptomatic visceral leishmaniasis: A cohort study. _PLoS Neglected Tropical Diseases_. 2019. Vol. 13, núm. 3, pàgs. e0007216. [consulta: 23 de gener de 2026]. ISSN: 1935-2735. [Disponible a: https://hdl.handle.net/2445/134893]

Exportar metadades

JSON - METS

Compartir registre